Posted inClinical Updates Oncology Urology
FGFR Alterations in Bladder Cancer: From Molecular Pathogenesis to Precision Oncology
FGFR alterations, especially in FGFR3 and FGFR2, are pivotal biomarkers in urothelial carcinoma, advancing personalized diagnosis, treatment, and monitoring across disease stages. Emerging molecular diagnostics and targeted therapies promise improved patient outcomes.
